Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crescent Biopharma, Inc. - Common Stock
(NQ:
CBIO
)
14.40
-0.07 (-0.48%)
Streaming Delayed Price
Updated: 12:08 PM EDT, Aug 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crescent Biopharma, Inc. - Common Stock
< Previous
1
2
3
4
Next >
CATALYST BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Catalyst Biosciences, Inc. - CBIO
December 30, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
CBIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Catalyst Biosciences, Inc. Is Fair to Shareholders
December 28, 2022
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 21, 2022
Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 21, 2022
We're starting Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares!
Via
InvestorPlace
Recap: Catalyst Biosciences Q1 Earnings
May 09, 2022
Catalyst Biosciences (NASDAQ:CBIO) reported its Q1 earnings results on Monday, May 9, 2022 at 08:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
How Is The Market Feeling About Catalyst Biosciences?
September 02, 2022
Catalyst Biosciences's (NASDAQ:CBIO) short percent of float has fallen 48.42% since its last report. The company recently reported that it has 918 thousand shares sold short,...
Via
Benzinga
JDS1, LLC Terminates Proxy Contest at Catalyst’s 2022 Annual Meeting
August 11, 2022
From
JDS1, LLC
Via
Business Wire
JDS1, LLC Files Definitive Proxy Statement and Sends Letter to Catalyst Stockholders
July 22, 2022
From
JDS1, LLC
Via
Business Wire
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
June 29, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
Via
Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
June 30, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.
Via
Benzinga
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
June 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 22, 2022
Via
Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
May 30, 2022
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for...
Via
Benzinga
20 Stocks Moving in Friday's Pre-Market Session
May 27, 2022
Gainers Adicet Bio, Inc. (NASDAQ: ACET) rose 16% to $11.90 in pre-market trading after reporting positive clinical update from ADI-001 Phase 1 Trial in relapsed/refractory Non-Hodgkin’s Lymphoma.
Via
Benzinga
88 Biggest Movers From Yesterday
May 27, 2022
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 25, 2022
Rise and shine, traders! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
50 Stocks Moving In Tuesday's Mid-Day Session
May 24, 2022
Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.
Via
Benzinga
Short Volatility Alert: Catalyst Biosciences
May 24, 2022
On Modnay, shares of Catalyst Biosciences, Inc. (NASDAQ: CBIO) experienced volatile short activity. After the activity, the stock price went up +234.21% to $1.27. The overall sentiment for CBIO has...
Via
Benzinga
25 Stocks Moving in Tuesday's Pre-Market Session
May 24, 2022
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 136.4% to $1.43 in pre-market trading. BOQI International recently posted a Q1 loss of $0.27 per share.
Via
Benzinga
Why Is Catalyst Biosciences (CBIO) Stock Soaring 170% Today?
May 23, 2022
Catalyst Biosciences (CBIO) stock is rocketing higher on Monday after announcing the sale of its protease medicines portfolio.
Via
InvestorPlace
Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex
May 23, 2022
Via
Benzinga
Why Catalyst Biosciences Shares Are Skyrocketing Today
May 23, 2022
Catalyst Biosciences Inc (NASDAQ: CBIO) shares are trading higher by 180.26% at $1.06 after the company announced it sold its complement portfolio for $60 million.
Via
Benzinga
58 Biggest Movers From Yesterday
May 24, 2022
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
Via
Benzinga
Looking Into Catalyst Biosciences's Return On Capital Employed
April 01, 2022
According to data from Benzinga Pro, during Q4, Catalyst Biosciences's (NASDAQ:CBIO) reported sales totaled $2.44 million. Despite a 19.45% increase in earnings, the company posted a loss of $20.33...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 15, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 17, 2022
Gainers Rhythm Pharmaceuticals (NASDAQ:RYTM) stock increased by 16.4% to $7.72 during Thursday's regular session. The current volume of 639.5K shares is 152.7% of...
Via
Benzinga
U.S. Xpress Enterprises And 4 Other Penny Stocks Bought By Insiders
February 17, 2022
Although US crude futures fell over 2% on Thursday, there were a few notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 07, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $22....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 07, 2022
With a weekend of rest under our belts, we're ready to jump back into investing with the biggest pre-market stock movers for Monday!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
February 16, 2022
On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.